Analysis of the protection afforded by annexin 1 in ischaemia-reperfusion injury: Focus on neutrophil recruitment

European Journal of Pharmacology

Volumn 429, Issue 1-3, 2001, Pages 263-278

  La, Mylinh ^a   Tailor, Anitaben ^b   D'Amico, Michele ^c   Flower, Roderick J ^a   Perretti, Mauro ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Annexin 1; fMLP (N formyl Met Leu Phe); Intravital microscopy; Mesentery; Myocardial infarct

Indexed keywords

ACETYLALANYLMETHIONYLVALYLSERYLGLUTAMYLPHENYLALANYLLEUCYLGLUTAMINYLALANYLTR YPTOPHYLPHENYLALANYLISOLEUCYLGLUTAMYLASPARAGINYLGLUTAMYLGLUTAMYLGLUTAMINYLGLUTAM YLTYROSYLVALYLGLUTAMINYLTHREONYLVALYLLYSINE; ANTIBODY; ANTIFLAMMIN 1; ANTIFLAMMIN 2; ANTIINFLAMMATORY AGENT; BETA2 INTEGRIN; CD31 ANTIGEN; CYTOPLASMIC RECEPTOR; DEXAMETHASONE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FREE RADICAL; GLUCOCORTICOID; IMMUNOGLOBULIN; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 2; INTERLEUKIN 1; INTERLEUKIN 1BETA; INTERLEUKIN 8; L SELECTIN; LEUKOTRIENE B4; LIPOCORTIN 1; MUCOSAL ADDRESSIN CELL ADHESION MOLECULE 1; PADGEM PROTEIN; RECOMBINANT LIPOCORTIN 1; THROMBOCYTE ACTIVATING FACTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

AMINO TERMINAL SEQUENCE; BLOOD VESSEL OCCLUSION; CELL ACTIVITY; COMPLEMENT FACTOR; DISEASE ASSOCIATION; DRUG MECHANISM; ENZYME INDUCTION; GENETIC TRANSCRIPTION; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HUMAN; INFLAMMATION; LEUKOCYTE ACTIVATION; LEUKOCYTE ADHERENCE; LEUKOCYTE MIGRATION; NEUTROPHIL CHEMOTAXIS; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN INDUCTION; REPERFUSION INJURY; REVIEW; STROKE;

ANIMALS; ANNEXIN A1; HUMANS; NEUTROPHIL INFILTRATION; REPERFUSION INJURY;

EID: 0035840833     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(01)01325-5     Document Type: Review

References (181)

1. Transient rise in serum interleukin-8 concentration during acute myocardial infarction
2. The biology of annexin I
3. Chemoattractant receptor cross-desensitization
4. Reperfusion injury: Experimental evidence and clinical implications
5. Monoclonal antibodies to the leukocyte membrane CD18 glycoprotein complex and to intercellular adhesion molecule-1 inhibit leukocyte-endothelial adhesion in rabbits
6. Interleukin-1 and thromboxane release after skeletal muscle ischemia and reperfusion
7. NADPH oxidase: An update
8. Anti-inflammatory actions of glucocorticoids: Molecular mechanisms
9. Human leukocyte granule elastase: Rapid isolation and characterization
10. Nitric oxide, superoxide and peroxynitrite: The good, the bad and the ugly
11. Identification of an inducible endothelial-leukocyte adhesion molecule
12. The role of interleukin-8 in inflammation and mechanisms of regulation
13. Splanchnic ischaemia/reperfusion and multiple organ failure
14. Changes in subcellular localization and surface expression of L-selectin, alkaline phosphatase, and Mac-1 in human neutrophils during stimulation with inflammatory mediators
15. Inhibition of interleukin-8 blocks myocardial ischemia-reperfusion injury
16. Blocking of classical complement pathway inhibits endothelial adhesion molecule expression and preserves ischemic myocardium from reperfusion injury
17. Human endothelial cells are target for platelet-activating factor: I. Platelet-activating factor induces changes in cytoskeleton structures
18. TCV-309, a novel platelet activating factor antagonist, inhibits leukocyte accumulation and protects against splanchnic artery occlusion shock
19. Pathophysiology of ischaemia-reperfusion injury
20. Protease inhibition attenuates microvascular dysfunction in postischemic skeletal muscle
21. Neutrophil elastase promotes lung microvascular injury and proteolysis of endothelial cadherins
22. Neutrophil activating factor (NAF) induces polymorphonuclear leukocyte adherence to endothelial cells and to subendothelial matrix proteins
23. Complement activation in heart diseases. Role of oxidants
24. Xanthine oxidase as a source of free radical damage in myocardial ischemia
25. Alterations in cell function with ischemia and shock and their correction
26. Differential recovery of skeletal muscle and peripheral nerve function after ischemia and reperfusion
27. Leukotriene B4 receptor transgenic mice reveal novel protective roles for lipoxins and aspirin-triggered lipoxins in reperfusion
28. Recombinant human lipocortin 1 inhibits thromboxane release from guinea-pig isolated perfused lung
29. Anti-inflammatory actions of an N-terminal peptide from human lipocortin 1
30. Acute reactant cytokines and neutrophil adhesion after warm ischemia in cirrhotic and noncirrhotic human livers
31. Complement activation following reoxygenation of hypoxic human endothelial cells: Role of intracellular reactive oxygen species. NF-kappaB and new protein synthesis
32. Glucocorticoid-induced annexin 1 secretion by monocytes and peritoneal leukocytes
33. Lipocortin 1 protects against splanchnic artery occlusion and reperfusion injury by affecting neutrophil migration
34. Beneficial effects of peroxynitrite decomposition catalyst in a rat model of splanchnic artery occlusion and reperfusion
35. Lipocortin 1 reduces myocardial ischemia-reperfusion injury by affecting local leukocyte recruitment
36. Neutrophil-activating protein 1/interleukin 8 stimulates the binding activity of the leukocyte adhesion receptor CD11b/CD18 on human neutrophils
37. Responses of the ischemic myocardium to allopurinol
38. The biological properties of interleukin-1
39. Biologic basis for interleukin-1 in disease
40. Interleukin-1
41. Proinflammatory cytokines
42. Differential expression of annexins I, II and IV in human tissues: An immunohistochemical study
43. Mediators of ischemia-reperfusion injury of rat lung
44. Differential modulation of annexin I binding sites on monocytes and neutrophils
45. Effect of platelet-activating factor on airway vascular permeability: Possible mechanisms
46. Lipocortin I (p35) is abundant in a restricted number of differentiated cell types in adult organs
47. Rapid leukocyte accumulation by "spontaneous" rolling and adhesion in the exteriorized rabbit mesentery
48. Lipocortin-1: Cellular mechanisms and clinical relevance
49. Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes
50. Comparative effect of C3a and C5a on adhesion molecule expression on neutrophils and endothelial cells
51. Biology of disease: Free radicals and tissue injury
52. Expression of VCAM-1 and E-selectin in an in vivo model of endothelial activation
53. Inhibition of neutrophil and monocyte recruitment by endogenous and exogenous lipocortin 1
54. In vitro activation of complement by isolated human heart subcellular membranes
55. Alterations in splanchnic cyclic nucleotide levels in splanchnic artery occlusion shock and their modification by dexamethasone
56. Oxygen free radicals are required for ischemia-induced leukotriene B4 synthesis and diapedesis
57. Mast cells and leukotrienes mediate neutrophil sequestration and lung edema after remote ischemia in rodents
58. Anti-inflammatory lipocortin 1 production by peripheral blood leucocytes in response to hydrocortisone
59. Evidence for specific annexin I-binding proteins on human monocytes
60. Ischaemia-reperfusion injury
61. Role of xanthine oxidase and granulocytes in ischemia-reperfusion injury
62. Ischemia-reperfusion: Mechanisms of microvascular dysfunction and the influence of risk factors for cardiovascular disease
63. Leukocyte-endothelial cell adhesion induced by ischemia and reperfusion
64. Biosynthesis, processing and sorting of neutrophil proteins: Insight into neutrophil granule development
65. Role of IL-1 in renal ischemic reperfusion injury
66. Studies on the chlorinating activity of myeloperoxidase
67. Platelet activating factor (PAF) induces the oxidative burst in macrophages
68. Increased serum concentrations of interleukin-1 beta in patients with coronary artery disease
69. Selection of a C5a receptor antagonist from phage libraries attenuating the inflammatory response in immune complex disease and ischemia/reperfusion injury
70. L-Selectin facilitates emigration and extravascular locomotion of leukocytes during acute inflammatory responses in vivo
71. The phlogistic role of C3 leukotactic fragments in myocardial infarcts of rats
72. Attenuation of neutrophil function by inhibitors of arachidonate metabolism reduces the extent of canine myocardial infarction
73. Free radical enhancement promotes leucocyte recruitment through a PAF and LTB4 dependent mechanism
74. Role of leukotriene B4 in the pathogenesis of hepatic ischemia-reperfusion injury in the rat
75. Anoxia-reoxygenation-induced, neutrophil-mediated endothelial cell injury: Role of elastase
76. Protective effects of L-659,989, a platelet-activating factor receptor antagonist, in myocardial ischemia and reperfusion in rats
77. Neutrophil chemoattractants generated in two phases during reperfusion of ischemic myocardium in the rabbit. Evidence for a role for C5a and interleukin-8
78. Production and release of platelet-activating factor by the injured heart-muscle cell (cardiomyocyte)
79. Factors involved in salvaging ischemic myocardium: Effect of reperfusion of arterial blood
80. High energy phosphates, anaerobic glycolysis and irreversibility in ischemia
81. Quantitation of intracellular Mac-1 (CD11b/CD18) pools in human neutrophils
82. The role of neutrophils in myocardial ischaemia-reperfusion injury
83. Molecular basis of complement activation in ischemic myocardium: Identification of specific molecules of mitochondrial origin that bind human C1q and fix complement
84. Hypoxic induction of interleukin-8 gene expression in human endothelial cells
85. Protective actions of a leukotriene B4 antagonist in splanchnic ischemia and reperfusion in rats
86. The complement system in myocardial ischaemia/reperfusion injury
87. Sulfhydryl compounds, captopril, and MPG inhibit complement-mediated myocardial injury
88. Neutrophil Mac-1 and MEL-14 adhesion proteins inversely regulated by chemotactic factors
89. Antibodies against human neutrophil LECAM-1 (LAM-1/Leu-8/DREG-56 antigen) and endothelial cell ELAM-1 inhibit a common CD18-independent adhesion pathway in vitro
90. Postischemic renal injury is mediated by neutrophils and leukotrienes
91. Myocardial reperfusion injury. Platelet-activating factor stimulates polymorphonuclear leukocyte hydrogen peroxide production during myocardial reperfusion
92. Leukocyte depletion attenuates vascular injury in postischemic skeletal muscle
93. Cell biology. Consensus in exocytosis
94. Modulation of PAF-induced leukocyte adherence and increased microvascular permeability
95. Role of platelet-activating factor in ischemia/reperfusion-induced leukocyte adherence
96. Therapeutic potential of inhibiting leukocyte rolling in ischemia/reperfusion
97. Annexins and membrane fusion
98. Interleukin-8 gene induction in the myocardium after ischemia and reperfusion in vivo
99. Role of selectins in myocardial ischemia-reperfusion injury
100. Pharmacology of the endothelium in ischemia-reperfusion and circulatory shock
101. Peroxynitrite inhibits leukocyte-endothelial cell interactions and protects against ischemia-reperfusion injury in rats
102. Synergism between platelets and neutrophils in provoking cardiac dysfunction after ischemia and reperfusion: Role of selectins
103. Regulation of inflammatory vascular damage
104. Promoting detachment of neutrophils adherent to murine postcapillary venules to control inflammation: Effect of lipocortin 1
105. Neutrophil depletion limited to reperfusion reduces myocardial infarct size after 90 minutes of ischemia. Evidence for neutrophil-mediated reperfusion injury
106. Neuroprotective effects of human recombinant interleukin-1 receptor antagonist in focal cerebral ischaemia in the rat
107. Coexpression of GMP-140 and PAF by endothelium stimulated by histamine or thrombin: A juxtacrine system for adhesion and activation of neutrophils
108. Cytokine-activated human endothelial monolayers support enhanced neutrophil transmigration via a mechanism involving both endothelial-leukocyte adhesion molecule-1 and intercellular adhesion molecule-1
109. Therapeutic inhibition of the complement system
110. Leukocyte transmigration, but not rolling or adhesion, is selectively inhibited by dexamethasone in the hamster post-capillary venule. Involvement of endogenous lipocortin 1
111. 'Antiflammins': Two nonapeptide fragments of uteroglobin and lipocortin I have no phospholipase A2-inhibitory and anti-inflammatory activity
112. Induction of cytokine expression in leukocytes in acute myocardial infarction
113. E/P-selectin-deficient mice: An optimal mutation for abrogating antigen but not tumor necrosis factor-alpha-induced immune responses
114. Oxygen-derived free radicals in postischemic tissue injury
115. Mouse model of myocardial remodelling after ischemia: Role of intercellular adhesion molecule-1
116. Novel anti-inflammatory peptides from the region of highest similarity between uteroglobin and lipocortin I
117. Peroxynitrite induced nitration and inactivation of myofibrillar creatine kinase in experimental heart failure
118. Intravascular release of platelet-activating factor during atrial pacing
119. Role of platelet-activating factor in cardiovascular pathophysiology
120. Regulation of the complement membrane attack pathway
121. An in vivo approach showing the chemotactic activity of leukotriene B(4) in acute renal ischemic-reperfusion injury
122. 1-O-Alkyl-sn-glyceryl-3-phosphorylcholines: A novel class of neutrophil stimulants
123. Neutrophil interaction with inflamed postcapillary venule endothelium alters annexin 1 expression
124. Glucocorticoid- and non-glucocorticoid induction of lipocortins (annexins) 1 and 2 in rat peritoneal leucocytes in vivo
125. Lipocortin-derived peptides
126. Endogenous mediators that inhibit the leukocyte-endothelium interaction
127. Modulation of IL-1-induced neutrophil migration by dexamethasone and lipocortin 1
128. Cytokines, glucocorticoids and lipocortins in the control of neutrophil migration
129. Lipocortin-1 fragments inhibit neutrophil accumulation and neutrophil-dependent edema in the mouse. A qualitative comparison with an anti-CD11b monoclonal antibody
130. The ability of murine leukocytes to bind lipocortin 1 is lost during acute inflammation
131. Mobilizing lipocortin 1 in adherent human leukocytes downregulates their transmigration
132. Modulation of cellular annexin I in human leukocytes infiltrating DTH skin reactions
133. Annexin I is stored within gelatinase granules of human neutrophil and mobilized on the cell surface upon adhesion but not phagocytosis
134. Alpha(4)-integrin mediates neutrophil-induced free radical injury to cardiac myocytes
135. The N-formyl peptide receptor: A model for the study of chemoattractant receptor structure and function
136. Lipid peroxidation and acute myocardial ischemia
137. Annexins: The problem of assessing the biological role for a gene family of multifunctional calcium- and phospholipid-binding proteins
138. Pathobiology of acute myocardial ischemia: Metabolic, functional and ultrastructural studies
139. Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat
140. Lipocortin-1 is an endogenous inhibitor of ischemic damage in the rat brain
141. Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog
142. Participation of the complement system in ischemia/reperfusion injury
143. Peroxynitrite decomposition catalysts: Therapeutics for peroxynitrite-mediated pathology
144. The discovery of the leukotrienes
145. Mechanisms and consequences of lipid peroxidation in biological systems
146. Interleukin 1 receptor blockade reduces tumor necrosis factor production, tissue injury, and mortality after hepatic ischemia-reperfusion in the rat
147. Detection of lipocortin 1 in human lung lavage fluid: Lipocortin degradation as a possible proteolytic mechanism in the control of inflammatory mediators and inflammation
148. Effect of specific neutrophil elastase inhibitor on ischemia/reperfusion injury in rat liver transplantation
149. Effects of a BLT receptor antagonist on local and remote reperfusion injuries after transient ischemia of the superior mesenteric artery in rats
150. Localization of immunoreactive lipocortin-1 in the brain and pituitary gland of the rat. Effects of adrenalectomy, dexamethasone and colchicine treatment
151. Interleukin 1 and tumor necrosis factor production as the initial stimulants of liver ischemia and reperfusion injury
152. Dexamethasone inhibition of leucocyte adhesion to rat mesenteric postcapillary venules: Role of intercellular adhesion molecule 1 and KC
153. L-selectin-deficient mice have impaired leukocyte recruitment into inflammatory sites
154. Adherence of neutrophils to cultured human microvascular endothelial cells. Stimulation by chemotactic peptides and lipid mediators and dependence upon the Mac-1, LFA-1, p150,95 glycoprotein family
155. Degradation of annexin I in bronchoalveolar lavage fluid from patients with cystic fibrosis
156. Myocardial infarction and apoptosis after myocardial ischemia and reperfusion: Role of the terminal complement components and inhibition by anti-C5 therapy
157. Degradation of adenine nucleotides in ischemic and reperfused rat heart
158. Intercellular adhesion molecule-1
159. Annexin 1 is overexpressed and specifically secreted during experimentally induced colitis in rats
160. Expression and secretion of lipocortin 1 in gut inflammation are not regulated by pituitary-adrenal axis
161. Reperfusion injury after focal myocardial ischaemia: Polymorphonuclear leukocyte activation and its clinical implications
162. Annexin I degradation in bronchoalveolar lavage fluids from healthy smokers: A possible mechanism of inflammation
163. Activation of the fifth component of human complement by oxygen-derived free radicals, and by methionine oxidizing agents: A comparison
164. L-selectin function is required for beta 2-integrin-mediated neutrophil adhesion at physiological shear rates in vivo
165. Generation of an activated form of human C5 (C5b-like C5) by oxygen radicals
166. A novel ligand of the formyl peptide receptor: Annexin I regulates neutrophil extravasation by interacting with the FPR
167. Specific, nongenomic actions of steroid hormones
168. Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement
169. Soluble human complement receptor type 1: In vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis
170. Neutrophils degrade subendothelial matrices in the presence of alpha-1-proteinase inhibitor. Cooperative use of lysosomal proteinases and oxygen metabolites
171. Neutrophil-mediated solubilization of the subendothelial matrix: Oxidative and nonoxidative mechanisms of proteolysis used by normal and chronic granulomatous disease phagocytes
172. Cloning of the mouse endothelial selectins. Expression of both E- and P-selectin is inducible by tumor necrosis factor alpha
173. Crystal structure of human annexin I at 2.5 A resolution
174. In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury
175. Monoclonal antibody to ICAM-1 preserves postischemic blood flow and reduces infarct size after ischemia-reperfusion in rabbit
176. Predominant role for C5b-9 in renal ischemia/reperfusion injury
177. Reperfusion-induced leukocyte infiltration: Role of elastase
178. Role of leukotriene B4 in granulocyte infiltration into the postischemic feline intestine
179. Endothelial cell interactions with granulocytes: Tethering and signaling molecules
180. Molecular determinants of lipid mediator-induced leukocyte adherence and emigration in rat mesenteric venules
181. The anti-inflammatory peptides, antiflammins, regulate the expression of adhesion molecules on human leukocytes and prevent neutrophil adhesion to endothelial cells